Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Snell

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|January 10, 2013
Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimeticKentaro Hashimoto, Bunnai Saito, Naoki Miyamoto, et al.
Bioorganic & Medicinal Chemistry|January 3, 2012
A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamidesKentaro Rikimaru, Takeshi Wakabayashi, Hidenori Abe, et al.
Journal of Medicinal Chemistry|March 7, 2018
Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse AgonistMitsunori Kono, Atsuko Ochida, Tsuneo Oda, et al.
Bioorganic & Medicinal Chemistry|April 17, 2012
Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR) γ AgonistsKentaro Rikimaru, Takeshi Wakabayashi, Hidenori Abe, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding ModeJun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Journal of Medicinal Chemistry|January 10, 2013
Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimeticKentaro Hashimoto, Bunnai Saito, Naoki Miyamoto, et al.
Bioorganic & Medicinal Chemistry|January 3, 2012
A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: design and synthesis of benzylpyrazole acylsulfonamidesKentaro Rikimaru, Takeshi Wakabayashi, Hidenori Abe, et al.
Journal of Medicinal Chemistry|March 7, 2018
Discovery of [ cis-3-({(5 R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1 H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5 H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse AgonistMitsunori Kono, Atsuko Ochida, Tsuneo Oda, et al.
Bioorganic & Medicinal Chemistry|April 17, 2012
Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR) γ AgonistsKentaro Rikimaru, Takeshi Wakabayashi, Hidenori Abe, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding ModeJun Fujimoto, Osamu Kurasawa, Terufumi Takagi, et al.
Pageof 5